Blog Post from the ALS Association

Amylyx Files NDA for AMX0035

Congrats and thank you to Amylyx Pharmaceuticals for moving swiftly to submit AMX0035 for approval. Thank you to ALL who advocated for this. We are urging the FDA to approve with urgency. Read more: https://bit.ly/AmylyxNDA

To hear more about the path to bringing AMX0035 to people with ALS, check out this discussion on Connecting ALS.

Comments

Submitted by: kevin C. on Sat, 01/29/2022

I have an ALS diagnosis and want to join to keep up with the progress for new treatments and am a proponent of Right to try Act. The Right to Try Act signed in 2018 avail us to try any drug that has reached Phase I. Our physicians must contact the sponsor of the drug to give their consent, we should not need the FDA to get any of these new meds, including AMX0035

Join the conversation. Please comment below.

CAPTCHA

Math question 3 + 3 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

November 4, 2021

Article Topic

Advocacy

Research